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mass ablation and is dependent on an intact renin-angiotensinProinflammatory gene expression and macrophage recruitment
system. We speculate that these responses may play a role inin the rat remnant kidney.
the pathogenesis of the ensuing glomerulosclerosis and tubulo-Background. Macrophage (M f ) infiltration may contribute
interstitial fibrosis.to chronic renal injury. We therefore sought to examine the
expression of genes associated with M f recruitment in the rat
remnant kidney model.
Methods. Male Munich Wistar rats underwent 5/6 nephrec-
Infiltration of glomeruli by cells of the monocyte/mac-tomy or sham operation (SHM, N 5 18) and received no treat-
rophage (M f ) series is a consistent finding in experimen-ment (VEH, N 5 18), enalapril 100 mg/L (ENA, N 5 18), or
candesartan 70 mg/L (CSN, N 5 24) in drinking water. Competi- tal and human glomerulonephritis. Several lines of evi-
tive, quantitative reverse transcription-polymerase chain reac- dence suggest that M f participate in the development
tion was used to determine renal cortex mRNA levels for cell
of acute glomerular injury through production of in-adhesion molecules vascular cell adhesion molecule-1 (VCAM-1)
flammatory mediators, including prostaglandins and cy-and intercellular adhesion molecule-1 (ICAM-1), the M f che-
moattractant monocyte chemoattractant protein-1 (MCP-1), tokines, and release of reactive oxygen radicals and pro-
Mf products interleukin-1b (IL-1b) and tumor necrosis factor-a teases [1, 2]. M f s have also been observed in remnant
(TNF-a), and the profibrotic cytokine transforming growth kidneys of rats subjected to extensive renal mass ablationfactor-b1 (TGF-b1), at intervals post-nephrectomy.
[3–7], a model of chronic renal disease (CRD) progres-Results. Glomerular and interstitial M f infiltration in VEH
sion in which the development of focal and segmentalrats was associated with an early (4 week) and sustained rise
in MCP-1 and TGF-b1 mRNA levels. Progressive increases in glomerulosclerosis (FSGS) and tubulointerstitial fibrosis
ICAM-1, VCAM-1, IL-1b, and TNF-a expression followed at (TIF) has been attributed largely to the adverse conse-
8 and 12 weeks. Immunostaining in VEH rats localized TGF-b1
quences of nephron loss, in particular, glomerular hyper-to glomeruli, tubules, and interstitium; MCP-1 to tubules and
perfusion and glomerular capillary hypertension [8]. Theinterstitial cells; ICAM-1 to glomeruli; and IL-1b and TNF-a
to tubules and interstitial cells. At 12 weeks, both treatments role of M f in the pathogenesis of CRD progression re-
normalized systolic blood pressure (ENA, 105 6 6; CSN, 97 6 mains unclear, but a growing body of evidence suggests
3 mm Hg) and the urinary protein excretion rate (ENA, 8.4 6 that Mf may participate in chronic renal injury processes0.9; CSN, 5.7 6 0.8 mg/day), prevented renal injury (focal and
not conventionally considered inflammatory in nature.segmental glomerulosclerosis: ENA, 3.3 6 0.9; CSN, 1.3 6
0.4%), and suppressed M f infiltration and cytokine expression A possible mechanistic link between altered glomerular
(with the exception of TNF-a) to near SHM levels. hemodynamics and M f recruitment is suggested by in
Conclusions. These findings support the hypothesis that the vitro studies showing that exposure of glomerular cellscoordinated up-regulation of several molecules regulating M f
to mechanical stresses results in the induction of pro-recruitment and activation is a fundamental response to renal
inflammatory molecules [9–12]. Angiotensin II (Ang II),
an important regulator of glomerular hemodynamics
1Drs. Taal and Zandi-Nejad contributed equally to this work. strongly implicated in the maintenance of glomerular
capillary hypertension and in CRD progression, may alsoKey words: ACE inhibition, glomerulosclerosis, nephrectomy, macro-
phage, transforming growth factor-b, ICAM, VCAM. contribute directly to the development of a proinflam-
matory microenvironment in the remnant kidney by acti-
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Further, tubule absorption of the increased amounts of from each group were sacrificed at 4, 8, and 12 weeks
after surgery. Before sacrifice, rats were anesthetized,filtered protein resulting from impaired glomerular bar-
rier function to macromolecules (also a consequence of and portions of renal cortex from areas that were distant
from the infarct scar were excised and snap frozen inglomerular capillary hypertension) may induce proinflam-
matory gene expression in renal tubule cells [7, 16–18], liquid nitrogen for subsequent extraction of RNA. The
rest of the remnant kidney was then removed and fixedproviding a link between augmented glomerular hemo-
dynamics and the activation of chronic, low-grade tubu- in 10% phosphate-buffered formalin.
lointerstitial inflammation.
Competitive reverse transcription-polymeraseThus, a substantial body of in vitro data suggests that
chain reactionthe expression of cell adhesion and chemotactic mole-
cules necessary for monocyte recruitment and activation Total RNA was extracted from frozen portions of re-
nal cortex by the cesium chloride ultracentrifugationmay be induced in vivo in response to glomerular capil-
lary hypertension, in the absence of classic “immune” method [22]. RNA was quantitated by determination
of ultraviolet absorbance at 260 nm, and its purity wasor acute inflammatory stimuli. Previous in vivo studies
have examined the expression of only one or two cyto- assessed by measuring the optical density ratio at 260
and 280 nm. For preparation of cDNAs, 4 mg of heat-kines together in temporal relationship to M f infiltration
in the remnant kidney model. In this study, we sought denatured RNA was used in a reverse transcription (RT)
reaction. The entire sample in a total volume of 20 mLto test the hypothesis that coordinated up-regulation of
several factors promoting M f recruitment is a fundamen- contained 4 mg of RNA, 0.5 mmol/L each of dATP,
dCTP, dGTP, and dTTP (Pharmacia Biotech Inc., Pisca-tal response to renal mass ablation and that inhibition
of the renin-angiotensin system (RAS), which leads to taway, NJ, USA), 0.5 mg oligo-d(T)12-18 (Pharmacia
Biotech Inc.), 40 U RNasin ribonuclease inhibitor (Pro-virtually complete protection from progressive renal in-
jury after 5/6 nephrectomy [19–21], suppresses this coor- mega, Madison, WI, USA), 200 U M-MLV reverse tran-
scriptase (Life Technologies, Gaithersburg, MD, USA)dinated response.
in a buffer of 50 mmol/L Tris-HCl (pH 8.3), 75 mmol/L
KCl, 3 mmol/L MgCl2, and 10 mmol/L dithiothreitol.METHODS
The solution was incubated for 60 minutes at 378C and
Animals was then held at 958C for 5 minutes to arrest the reaction.
Preparations of cDNA were then used as substrateMale Munich-Wistar rats (weight 230 to 310 g) were
obtained from Simonsen Laboratories (Gilroy, CA, for competitive polymerase chain reaction (PCR) using
competitive DNA mimics and oligonucleotide primer setsUSA), housed under standard conditions, and given un-
restricted access to standard rodent chow and water. (Genosys Biotechnologies, Inc., Woodlands, TX, USA).
Competitive DNA mimics for each factor, comprising aRats were subjected either to renal mass ablation by
right nephrectomy and ligation of two or three branches segment of neutral DNA with sequences complementary
to the gene-specific primers attached to each end, wereof the left renal artery, producing infarction of approxi-
mately two thirds of the left kidney (N 5 60), or to sham constructed using a PCR MIMIC Construction Kit (Clon-
tech Laboratories, Inc., Palo Alto, CA, USA). Primer setsoperation by laparotomy and mobilization of the renal
vessels (SHM, N 5 18). All surgical procedures were were designed for rat vascular cell adhesion molecule-1
(VCAM-1), intercellular adhesion molecule-1 (ICAM-1),performed under pentobarbital anesthesia (Nembutal 50
mg/kg intraperitoneally; Abbott Laboratories, Chicago, monocyte chemoattractant protein-1 (MCP-1), interleu-
kin-1b (IL-1b), tumor necrosis factor-a (TNF-a), trans-IL, USA). On day 4 after renal mass ablation, rats were
started on candesartan cilexetil (Takeda Chemical In- forming growth factor-b1 (TGF-b1), and glyceralde-
hyde-3-phosphate dehydrogenase (GAPDH) based ondustries, Osaka, Japan) 70 mg/L (4 to 10 mg/kg/day) in
the drinking water with vehicle [ethanol (0.1% vol/vol), published cDNA sequences [23, 24]. An equal volume
of each cDNA solution was used for amplification inpolyethylene glycol (0.1% vol/vol) and sodium bicarbon-
ate (1 mmol/L)] added to solubilize candesartan (CSN, 20 mL of reaction mixture containing competitive DNA
mimic, 0.5 mmol/L primer sets, 0.5 U Taq DNA polymer-N 5 24) or enalapril (Merck Research Laboratories,
Rahway, NJ, USA) 100 mg/L (6 to 14 mg/kg/day) in ase (Pharmacia Biotech Inc.); 250 mmol/L each of dATP,
dCTP, dGTP, and dTTP (Pharmacia Biotech Inc.) indrinking water (ENA, N 5 18). Controls received vehicle
alone (VEH, N 5 18). At four-week intervals, systolic a buffer of 10 mmol/L Tris-HCl (pH 9.0) and optimal
concentration of MgCl2. PCR was performed using ablood pressure (SBP) was measured by the tail-cuff
method and daily urinary protein excretion rate (UprV) Peltier Thermal Cycler (MJ Research Inc., Watertown,
MA, USA). Optimal PCR conditions, namely concentra-determined by spectrophotometry after precipitation
with 3% sulfosalicylic acid on urine collected from rats tion of competitive DNA mimic, annealing temperature,
and amplification cycles, were determined for each factorindividually housed in metabolic cages for 24 hours. Rats
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Table 1. Summary of primer sequences and PCR conditions
Size Annealing
Primer Sense sequence Antisense sequence bp temperature 8C
MCP-1 ATG CAG GTC TCT GTC ACG CTA GTT CTC TGT CAT ACT 447 55
TGF-b1 CTT CAG CTC CAC AGA GAA GAA CTG C CAC GAT CAT GTT GGA CAA CTG CTC C 298 64
TNF-a TAC TGA ACT TCG GGG TGA TTG GTC C CAG CCT TGT CCC TTG AAG AGA ACC 295 65
IL-1b TGA TGT TCC CAT TAG ACA GC GAG GTG CTG ATG TAC CAG TT 378 55
ICAM-1 AGA AGG ACT GCT TGG GGA A CCT CTG GCG GTA ATA GGT G 332 60
VCAM-1 CTG ACC TGC TCA AGT GAT GG GTG TCT CCC TCT TTG ACG CT 260 60
GAPDH AAT GCA TCC TGC ACC ACC AA GTA GCC ATA TTC ATT GTC ATA 516 55
Abbreviations are: MCP-1, monocyte chemoattractant protein-1; TGF-b1, transforming growth factor-b1; TNF-a, tumor necrosis factor-a; IL-1b, interleukin-1b;
ICAM-1, intercellular adhesion molecule-1; VCAM, vascular cell adhesion molecule; GAPDH; glyceraldehyde-3-phosphate dehydrogenase.
in preliminary studies. Amplification was initiated with treatment group on gene expression, all specimens from
a given time point were then assayed together in singleincubation at 948C for two minutes followed by amplifi-
PCR reactions. To provide uniformity in these lattercation cycles as follows: 948C for 15 seconds, annealing
three cross-group data sets, data were expressed as ratiostemperature for 30 seconds, 728C for 1 minute. Sequences
to the mean value for the SHM group at each timeof oligonucleotide primer sets and optimal conditions
point. GAPDH mRNA levels were used to confirm thatare listed in Table 1. PCR products (7 mL) were subjected
starting amounts of cDNA were similar among groups.to gel electrophoresis (5% polyacrylamide), and then
DNA bands were visualized under ultraviolet light after
Immunohistochemistryethidium bromide staining (0.05 mg/mL for 10 minutes)
Macrophage infiltration and expression of ICAM-1,and were photographed (Fig. 1A). Densities of competi-
MCP-1, IL-1b, TNF-a, and TGF-b1 proteins were as-tive mimic and target gene DNA bands were measured
sessed by immunohistochemistry. For this purpose, 4 mmby scanning densitometry using ScanJet 4c (Hewlett
thick paraffin sections of formalin-fixed tissues were usedPackard, Corvallis, OR, USA) with NIH Image software.
for immunoperoxidase analysis after baking at 608C forThe ratios of the densities of the respective bands were
one hour and deparaffinization and rehydration (100%plotted to establish a linear relationship of the ratios
xylene 3 4 for three minutes each, 100% ethanol 3 4over serial dilutions of template (Fig. 1B). Thus, absolute
for three minutes each and running water for five min-amounts of mRNA from unknown samples were calcu-
utes). The sections were then microwave treated at 938Clated as previously described [23, 25] from the known
for 30 minutes in preheated 10 mmol/L citrate buffer, pHamount of the mimic in the starting reaction using this
6.0, cooled for 15 minutes, and transferred to phosphate-formula:
buffered saline (PBS). Sections were then blocked with
[target gene] 5 [mimic] 3 a 1.5% solution of serum of the species from which the
secondary antibody was derived at room temperature([target gene product] 4 [mimic product])1/a
for 15 minutes. Next, sections were incubated with mouse
where a 5 gradient of the log plot of [target gene prod- monoclonal antibodies against rat ICAM-1 (clone CD54,
uct]:[mimic product] versus serial dilutions of starting 1:150 dilution; Biosurface International, Camarilla, CA,
cDNA (Fig. 1B). This method has been deemed as accu- USA), hamster anti-mouse MCP-1, which cross-reacts
rate as scintillation counting of radiolabeled PCR prod- with rat MCP-1 (clone 2H5, 1:50 dilution; Biosurface
ucts [26]. Specimens were run in duplicate, and the aver- International), rabbit polyclonal antibodies against rat
age value was used. In addition, for one specimen, extra IL-1b (1:100 dilution; Endogen, Woburn, MA, USA),
tubes were added containing half and double the stan- TNF-a (1:50 dilution; Endogen), TGF-b1(V) (1:150 dilu-
dard amount of cDNA. Figure 1C confirms the linear tion; Santa Cruz Biotechnology Inc., Santa Cruz, CA,
relationship between the amount of cDNA added to the USA), and mouse monoclonal antibodies to the rat
reaction and the estimated target gene concentration, monocyte/M f marker ED1 (clone ED1, 1:150 dilution;
and shows that the assay is consistently capable of de- Biosurface International) for one hour in a humid cham-
tecting a twofold difference in target gene concentration ber at room temperature. The secondary antibody (Vecta-
[23]. As the number of specimens exceeded the capacity stain Elite ABC Kit; Vector Laboratories Inc., Burlington,
of the thermal cycler, all specimens from the study could CA, USA) was used according to the manufacturer’s in-
not be included in a single PCR reaction. Specimens structions. Slides were rinsed with PBS between each
from VEH and SHM groups at each time point were incubation. Sections were developed using 3,39-diamino-
initially run together to determine the time course of gene benzidine (Sigma Chemical Company, St. Louis, MO,
USA) as substrate and were counterstained with Gill’sexpression after 5/6 nephrectomy. To assess the effect of
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Fig. 1. (A) Polyacrylamide gel showing electrophoretic bands for mimic and gene-specific (ICAM-1) cDNA at different amounts of starting cDNA.
(B) Log-log plot of starting cDNA amount versus the ratio of gene-specific (ICAM-1):mimic PCR product concentration showing a linear relationship
over serial dilutions of starting cDNA. (C) Linear plot of starting cDNA amount versus ICAM-1 concentration determined by competitive
RT-PCR illustrating the feasibility of detecting a twofold difference in gene expression with this assay.
Hematoxylin (Fisher Scientific, Pittsburgh, PA, USA). global sclerosis as a percentage of the total number of
glomeruli counted for each rat (.70 per rat). Tubulo-Specimens in which the previous procedure was repeated
but with the primary antibody omitted or substituted interstitial injury was assessed at medium power on the
same sections. Each of three parameters of tubulointer-with preimmune serum from the respective species of
the primary antibody served as negative controls. stitial injury (tubule proteinaceous casts and dilation,
interstitial inflammation, interstitial fibrosis) was as-Macrophage infiltration was assessed by counting the
number of ED1-positive cells in 30 glomerular profiles signed a score from 0 to 3 according to severity (0 5 no
abnormality, 1 5 mild, 2 5 moderate, 3 5 severe), andand in 20 randomly chosen 0.25 3 0.25 mm areas of
tubulointerstitium for each kidney. these scores added to yield an overall tubulointerstitial
score (TIS) from 0 to 9 (arbitrary units). The pathologist
Morphology was unaware of the group assignment of individual rats.
Renal tissue was embedded in paraffin and was pro-
Statistical analysiscessed for light microscopy. The frequency of FSGS was
estimated by examining all glomeruli seen in one or two Continuous variables are expressed as mean 6 SEM.
Differences among multiple groups were assessed usingcoronal sections from each kidney stained by the periodic
acid-Schiff method. Segmental sclerosis was defined as the Kruskal–Wallis test and between two groups with
the Mann–Whitney test. The null hypothesis was rejectedglomerular capillary collapse with hyaline deposition
and/or adhesion to the parietal layer of Bowman’s cap- at P , 0.05. Statistical analyses were conducted using
Statview 4.01 (Abacus Concepts Inc., Berkley, CA,sule. A glomerulosclerosis score was determined by ex-
pressing the number of glomeruli with segmental or USA).
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Table 2. Physiological data
N Baseline N 4 weeks N 8 weeks N 12 weeks
Weight g
SHM 18 26762 6 273611 6 322614 6 36064
VEH 18 27264 6 264616 6 317610 6 342618
ENA 18 27263 6 249613 6 31764 6 33867b
CSN 24 26763 9 28265 6 30167 9 33466b
SBP mm Hg
SHM 18 13064 6 12363a 6 12363a 6 10962a
VEH 18 13163 6 173613 6 15669 6 17268
ENA 18 12463 5 10065a,b 6 10563a,b 6 10566a
CSN 24 12862 9 9667a,b 6 10065a,b 9 9763a,b
UprV mg/day
SHM 18 4.760.4 6 6.061.2a 6 7.462.4a 6 9.461.3a
VEH 15 4.960.5 6 58614 6 4462.9 6 93612
ENA 18 5.460.5 6 2.060.3a,b,c 6 4.661.0a 6 8.460.9a,c
CSN 24 4.560.4 9 3.460.3a,b 6 6.163.4a 9 5.760.8a
Abbreviations are: SHM, sham operated; VEH, vehicle-treated; ENA, enalapril; CSN, candesartan groups; SBP, systolic blood pressure, UprV, urinary protein
excretion rate.
aP , 0.05 vs. VEH; bP , 0.05 vs. SHM; cP , 0.05 vs. CSN by Kruskal-Wallis and Mann-Whitney tests
Table 3. Histologic dataRESULTS
4 weeks 8 weeks 12 weeksGeneral data
Glomerulosclerosis %Before surgery, there were no differences among
SHM 0.160.06a 1.160.6a 2.160.5a
groups with respect to body weight, SBP, or UprV (Table VEH 27.165.6 34.665.4 62.364.1
ENA 1.7 61.0a,b 1.760.6a 3.360.9a2). Body weight increased in all groups throughout the
CSN 1.060.2a,b 4.962.1a 1.360.4astudy, but was marginally lower in ENA and CSN rats
Tubulointerstitial score 0–9
than SHM rats at 12 weeks. Following 5/6 nephrectomy, SHM 0.060.0a 0.060.0a 0.060.0a
VEH 1.3 60.4 1.160.3 3.660.7SBP increased in VEH, but not in ENA or CSN rats.
ENA 0.0 60.0a 0.060.0a 0.060.0aIndeed, treatment with enalapril or candesartan lowered CSN 0.360.1 0.060.0a 0.060.0a
SBP to levels below those observed in SHM rats. A Glomerular mf
cells/glomerular profileprogressive rise in UprV was observed in VEH, but not
SHM 0.360.1a 0.360.1a 0.360.04ain SHM, ENA, or CSN rats. Although UprV levels at VEH 3.2 60.4 3.360.5 3.760.3
four weeks were lower in ENA and CSN than SHM rats, ENA 0.8 60.1a,b 0.760.1a,b 0.560.2a
CSN 0.660.1a,b 1.060.1a,b 0.760.1a,bsimilar tendencies were not significant at 8 and 12 weeks.
Interstitial mfSevere, progressive FSGS and TIF developed in the rem- cells/0.0625 mm2
SHM 0.260.1a 0.560.2a 0.260.04anant kidneys of VEH rats over time, whereas treatment
VEH 3.9 60.5 4.760.9 4.261.2with enalapril or candesartan markedly limited renal in-
ENA 0.9 60.2a,b 0.760.1a 0.660.1a,b
jury to levels not significantly different from those ob- CSN 0.960.2a,b 1.260.2a,b 0.660.07a,b
served in SHM rats (Table 3). Abbreviations are: SHM, sham operated; VEH, vehicle-treated; ENA, enala-
pril; CNS, candesartan groups.
aP , 0.05 vs. VEH, bP , 0.05 vs. SHM by Kruskal-Wallis and Mann-WhitneyCompetitive RT-PCR
tests
Mean values for GAPDH mRNA levels, determined
by competitive RT-PCR, were similar among the groups
in each set of PCR reactions, confirming that the determi-
proximately twofold statistically significant increases be-nations of starting concentrations of cDNA were not
came evident for each of these factors in VEH rats at 8subject to systematic error. Data for each gene are pre-
and 12 weeks (Fig. 2). In contrast, marked increases insented here as absolute values (and not as a ratio to
renal cortical mRNA levels for TGF-b1 (approximatelyGAPDH) because GAPDH and target gene mRNA lev-
threefold vs. SHM) and MCP-1 (approximately fourfold)els were not determined on the same aliquot of cDNA
were observed at four weeks after surgery in VEH rats,with competitive RT-PCR. However, when calculated
elevations that were sustained at 8 and 12 weeks (Fig.as a ratio to GAPDH, the patterns of expression ob-
2). Treatment with enalapril or candesartan virtually ab-tained were very similar to the patterns seen with the
rogated the respective elevations in mRNA levels forabsolute values. Although no differences in mRNA lev-
VCAM-1, ICAM-1, MCP-1, IL-1b, and TGF-b1 at 12els for VCAM-1, ICAM-1, IL-1b, or TNF-a between
VEH and SHM rats were observed at four weeks, ap- weeks, such that each remained similar to the values
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Fig. 2. Renal cortex mRNA levels for studied genes in vehicle (VEH; h) and sham-operated (SHM; j) rats at time points post-surgery. Levels
for MCP-1 and TGF-b1 were significantly increased in VEH rats at four weeks and at subsequent time points. ICAM-1, VCAM-1, IL-1b, and
TNF-a levels were up-regulated in VEH rats from eight weeks. There were no significant differences in GAPDH mRNA levels among the groups.
*P , 0.05 vs. SHM at each time point; †P , 0.05 vs. VEH at 4 weeks; §P , 0.05 vs. SHM at 4 weeks by Kruskal-Wallis and Mann-Whitney tests.
observed in SHM rats (Fig. 3). mRNA levels for MCP-1 TNF-a mRNA levels were significantly inhibited in ENA
rats. Similar patterns of expression were obtained with-and TGF-b1 were marginally higher in CSN versus SHM
rats at 12 weeks, but values in both treated groups were out factoring gene expression for the mean SHM value
markedly lower than those of VEH. The tendency for (data not shown).
TNF-a mRNA levels to be lower in both ENA and CSN
Immunohistochemistryrats versus VEH did not achieve statistical significance;
indeed, TNF-a levels remained significantly greater in Immunohistology confirmed that the increases in
mRNA levels described previously in this article wereCSN than SHM rats. When mRNA levels for each mole-
cule were expressed as a ratio to the respective mean accompanied by corresponding increases in protein ex-
pression in VEH rats and allowed localization of theSHM value, trends among the groups at earlier time
points were similar to those observed at 12 weeks (Table enhanced expression within the remnant kidney (Fig. 4).
TGF-b1 staining was strongly positive in the glomeruli,4). The up-regulation of TGF-b1 at four weeks was effec-
tively prevented by enalapril and candesartan, whereas tubules, and interstitium of remnant kidneys in VEH
rats at all time points. Staining for MCP-1 was presentthe increase in mRNA levels for MCP-1 was only par-
tially inhibited by enalapril and candesartan. At eight in tubule cells and interstitial cells within areas of cellular
infiltration in VEH rats at 4, 8, and 12 weeks. Stainingweeks after surgery, up-regulation of VCAM-1, ICAM-
1, and MCP-1 was largely blocked en masse in both ENA for IL-1b and TNF-a also was largely localized to tubule
epithelial cells. For TNF-a, occasional positive-stainingand CSN groups; increases in TGF-b1, IL-1b, and
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Fig. 3. Effect of treatment with candesartan cilexetil ( ) or enalapril ( ) on renal cortex mRNA levels for studied genes at 12 weeks after 5/6
nephrectomy. Both treatments suppressed the up-regulation of mRNA for VCAM-1, ICAM-1, MCP-1, IL-1b, and TGF-b1 observed in VEH rats
(h) to levels that were similar to or only slightly higher than those of SHM rats (j). TNF-a mRNA levels were not significantly suppressed by
either treatment. There were no significant differences in GAPDH mRNA levels among the groups. *P , 0.05 vs. VEH; †P , 0.05 vs. SHM;
§P , 0.05 vs. CSN by Kruskal-Wallis and Mann-Whitney tests.
cells were also present in glomeruli and areas of intersti- Controls in which the primary antibody was omitted
were negative apart from some staining of erythrocytes.tial inflammation. In contrast, staining for ICAM-1 was
localized to the glomeruli of VEH rats, in particular to Controls in which preimmune serum from the appro-
priate species was substituted for the primary antibodythe glomerular capillary loops, and was strongly positive
at all time points. Peritubular capillaries were also posi- showed only minimal background staining. The use of
preimmune mouse serum was associated with positivetive for ICAM-1. Weak staining for ICAM-1 was accom-
panied, in some tubules, by positive staining of the epi- staining of intraluminal tubular proteinaceous casts
(Fig. 4).thelial cell brush border. Staining for TGF-b1, MCP-1,
ICAM-1, and IL-1b appeared much weaker in kidneys
Macrophage infiltrationfrom SHM or those from ENA and CSN rats. For TGF-
b1, glomerular staining was absent in SHM and treated Macrophage infiltration was evident in both the glo-
meruli and interstitium of remnant kidneys in VEH rats.rats, and tubule staining was only weakly positive. Glo-
meruli of SHM rats were generally negative for ICAM-1, At four weeks after surgery, the number of M f s was
markedly increased in VEH versus SHM rats, by approx-and although some stained positive in ENA and CSN
rats, staining was of lesser intensity than in VEH rats. imately 10-fold in glomeruli and 20-fold in the intersti-
tium. These increases were sustained at 8 and 12 weeks.In contrast, immunostaining of tubules for TNF-a did
not appear to be reduced either in ENA or CSN rats. Treatment with enalapril or candesartan largely pre-
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Table 4. Mean renal cortical mRNA levels for cell adhesion the hypothesis that regulated recruitment of M f plays an
molecules and cytokines expressed as a ratio to SHM
important role in the pathogenesis of chronic progressive
4 weeks 8 weeks 12 weeks renal injury resulting from extensive nephron loss.
VCAM-1 Recruitment of M f in acute inflammatory settings is
VEH 1.8560.18 1.3660.08 2.1560.43 thought to involve cytokine-induced endothelial cell ad-
ENA 0.8860.10a 1.0360.1a 1.3960.11
hesion molecule (CAM) expression, margination, diape-CSN 1.3060.19 1.1460.13 1.2860.20
ICAM-1 desis, and migration of M f into tissues down a chemotac-
VEH 1.4160.20 1.5060.14 2.1460.29 tic gradient [reviewed in 2, 28]. In the remnant kidney,
ENA 0.8860.09a 0.6660.06a 1.3360.21
alternative mechanisms may operate to initiate M f accu-CSN 1.0260.14 0.8560.14a 1.3160.24a
MCP-1 mulation in the absence of major acute inflammatory or
VEH 11.963.53 2.6460.18 2.6760.23 immune stimuli (for example, induction of CAMs and
ENA 7.2561.60 1.2960.12a 1.0060.11a,b
chemoattractants in glomerular cells exposed to mechan-CSN 5.1261.06a 1.3960.31a 1.4160.16a
IL-1b ical forces [9, 10], in situ proliferation of M f [4, 6], renal
VEH 2.0860.45 3.4460.58 1.8060.20 tubule cell complement activation as well as expression
ENA 2.5360.57 0.7560.13a,b 1.0260.17a
of CAMs and chemoattractants following their uptakeCSN 3.0460.72 2.6660.85 1.1060.13a
TNF-a of abnormal amounts of protein [7, 16, 29]).
VEH 2.0260.27 1.4460.17 3.4060.52 We have observed approximately twofold increases in
ENA 1.3360.26 0.5560.08a,b 1.8260.35a
renal cortex mRNA levels for VCAM-1 and ICAM-1,CSN 1.2460.07a 1.0460.16 2.4660.40
TGF-b1 adhesion molecules critical for monocyte recruitment, in
VEH 2.8760.35 2.7860.42 3.7660.63 untreated rats at 8 and 12 weeks after 5/6 nephrectomy.
ENA 0.7360.16a,b 0.5560.08a,b 1.2760.18a
Increases in ICAM-1 and VCAM-1 mRNA were alsoCSN 1.3460.20a 2.1160.32 1.6360.18a
GAPDH observed in kidneys from rats subjected to unilateral
VEH 1.2360.13 0.9660.16 1.1960.19 ureteric obstruction (UUO) [30], a model characterized
ENA 1.1160.17 1.0360.14 0.9060.06
by interstitial M f infiltration and fibrosis [31]. In ourCSN 1.2460.14 1.2260.28 1.0460.15
study, immunohistochemistry revealed positive stainingAbbreviations are: VEH, vehicle-treated; ENA, enalapril; CNS, candesartan
groups. for ICAM-1 in glomeruli and, to a lesser extent, in tu-
aP , 0.05 vs. VEH; bP , 0.05 vs. CSN by Kruskal-Wallis and Mann-Whitney bules, a pattern similar to that observed in immune-tests
complex–mediated nephropathies [32–34]. ICAM-1 ex-
pression may be induced in endothelial cells exposed in
vitro to shear stress [9]. Therefore, shear stress caused by
altered glomerular hemodynamics in the remnant kidneyvented glomerular and tubulointerstitial M f infiltration,
although M f numbers were marginally, but significantly, may conceivably account for the induction ICAM-1 in
the glomerular endothelium. Although we anticipatedhigher in the treated groups versus SHM. There were
that ICAM-1 would be up-regulated at four weeks afterno differences in M f numbers between ENA and CSN
5/6 nephrectomy in VEH rats due to glomerular hyper-rats (Table 3).
perfusion, we did not detect a significant increase in
ICAM-1 mRNA levels in renal cortex. However, in-
DISCUSSION creased glomerular ICAM-1 immunostaining was ob-
Macrophages represent a prominent component of in- served at four weeks. Difficulty in detecting relatively
flammatory cell infiltrates in several forms of experimen- small increments in glomerular ICAM-1 mRNA may be
tal and human glomerulonephritis and are thought to due to “dilution” in the face of stable levels of ICAM-1
contribute directly to glomerular injury through secre- mRNA originating from nonglomerular portions of the
tion of reactive oxygen species, proteases, eicosanoids, cortex; alternatively, post-transcriptional regulation of
and cytokines [1, 2]. Our data confirm previous observa- glomerular ICAM-1 expression may occur.
tions that M f infiltrate the remnant kidney in response Ingestion by renal tubule cells of grossly elevated
to extensive renal mass ablation [3–7], attaining near amounts of filtered protein, as occurs in the protein over-
maximum levels at four weeks after surgery, preceding load model, results in interstitial M f infiltration associ-
evidence of severe renal injury [3, 5]. The infiltration of ated with increased tubule expression of both VCAM-1
Mf in advance of renal injury in this model suggests that and ICAM-1 [16]. Similar mechanisms may supervene
Mf recruitment is a response to nephron loss per se and in the 5/6 nephrectomy model after four weeks, in re-
not merely part of the healing response to renal injury. sponse to the cumulative effects of significant proteinuria
When taken together with observations that short-term [7, 29].
depletion of M f by irradiation results in a transient re- Monocyte chemoattractant protein-1 is a specific
duction in mesangial matrix expansion in partially ne- monocyte chemoattractant associated with renal M f in-
filtration in several experimental models of glomerulone-phrectomized rats [27], our findings are consistent with
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Fig. 4. Immunohistology. MCP-1 immunostaining was evident in tubule cells (A) and infiltrating interstitial cells (B), but was weakly positive or
negative in glomeruli (A) of remnant kidneys from VEH rats at 12 weeks after 5/6 nephrectomy. Weak tubule staining was observed in CSN rats
(C) and negative staining, in sham-operated SHM rats (D). ICAM-1 immunostaining was strongly positive in glomeruli of VEH rats at four weeks,
particularly in endothelial cells of glomerular capillaries (E). Positive staining was also observed along the brush border of tubule cells (E) and
in endothelial cells of peritubular capillaries (F ). CSN rats displayed only weak glomerular and tubule brush border staining (G), and kidneys
from SHM rats were negative for ICAM-1 (H). TNF-a immunostaining was positive in tubule cells and infiltrating cells in VEH rats (I ) and tubule
cells in CSN rats (K) at 12 weeks after 5/6 NPX. Staining was negative in kidneys from SHM rats (L). (J) A negative control in which the primary
antibody was omitted to exclude nonspecific binding of the secondary antibody to renal tissue. All panels 3250 magnification.
phritis [35–37], UUO [30], and human glomerulonephri- crease in renal cortex MCP-1 mRNA levels at 4 weeks,
which was sustained at 8 and 12 weeks. Like ICAM-1,tis [38–40]. In vitro observations suggest that MCP-1 may
also contribute to tissue injury by stimulating monocyte expression of MCP-1 is induced in endothelial cells ex-
posed to shear stress [10]. Elevated MCP-1 mRNA levelsactivation [41] and IL-1 production [42], as well as pro-
duction of TGF-b and collagen by fibroblasts [43]. Our have been observed in glomeruli from deoxycorticoster-
one acetate (DOCA)-salt hypertensive rats (abstract;data confirm and extend the findings of previous investi-
gators who have detected increases in renal MCP-1 Omer et al, J Am Soc Nephrol 9:619A, 1998) and from
aortas of hypertensive rats [44], strongly suggesting thatmRNA levels at two weeks after 5/6 nephrectomy by
Northern blot analysis [5]. We observed a fourfold in- mechanical forces also induce MCP-1 expression in vivo.
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Renal tubule cells cultured with abnormally high extra- 4 weeks and were sustained at 12 weeks. Immunostaining
revealed TGF-b1 expression in glomeruli, tubules, andcellular protein concentrations synthesize MCP-1 [17],
suggesting that MCP-1 expression by tubule epithelial interstitial cells. Several mechanisms may account for
the induction of TGF-b1 expression in this model: expo-cells in vivo and interstitial M f accumulation in the rem-
nant kidney may also occur in response to proteinuria. sure of endothelial cells to shear stress [11] and mesangial
cells to cyclical stretching [12], exposure of tubule cellsAlthough immunostaining was limited to tubule cells in
our study, previous studies in diabetic rats [23] and 5/6 to excess filtered protein [16], and direct effects of Ang II
on mesangial cells [14]. Thus, although TGF-b1 produc-nephrectomized rats [5] have observed positive staining
for MCP-1 in glomeruli. tion has often been associated with primary immune-
complex–mediated injury, the interplay of several anti-Tumor necrosis factor-a and IL-1b are important in-
flammatory cytokines that may be produced by infiltrat- gen-independent mechanisms may account for the early
up-regulation of TGF-b1 in this model.ing Mf or intrinsic renal cells [reviewed in 45, 46]. Both
TNF-a and IL-1b may play a role in sustaining inflam- As is well established, we found that treatment with
the angiotensin-converting enzyme inhibitor (ACEI),mation through autocrine and paracrine induction of
CAMs [28], chemotactic factors [38, 47, 48] and cytokines enalapril, or the angiotensin II type I receptor antagonist
(AT1RA) candesartan cilexetil resulted in almost com-[49, 50]. A previous study was unable to detect TNF-a or
IL-1b expression in the remnant kidney using Northern plete protection of the remnant kidney from progressive
injury [19–21]. Furthermore, the renoprotection achievedanalysis of whole kidney RNA [5], a technique that may
fail to detect genes with very low levels of expression. by RAS inhibition was associated with significantly fewer
infiltrating Mf and less proinflammatory gene expression,Using RT-PCR, we have observed approximately two-
fold increases in renal cortex mRNA levels for TNF-a suggesting that these latter processes are also dependent,
directly or indirectly, on the actions of Ang II. As shownand IL-1b at 8 and 12 weeks after 5/6 nephrectomy, at
which time-points M f infiltration and renal injury were in Figure 5, Ang II occupies a central role in many of
the pathways thought to contribute to the pathogenesiswell-established. Confirmatory immunohistology revealed
positive staining for TNF-a and IL-1b localized mainly of chronic injury in the remnant kidney. Renoprotection
with either ACEI or AT1RA is therefore likely to beto tubule and interstitial cells with occasional positive
glomerular cells. These findings are consistent with TNF-a achieved through the consequences of reduced effects
of Ang II in multiple pathways at multiple sites. Sinceand IL-1b playing a “downstream” role in maintaining
Mf infiltration and activation in the remnant kidney, but enalapril and candesartan achieved similar effects on all
parameters studied, we may also conclude that despiteperhaps not a critical role in initiating M f recruitment.
The apparent discrepancy between M f infiltration and differences in the pharmacology of ACEI and AT1RA,
both agents exert their renoprotective effects primarilythe expression of the M f products TNF-a and IL-1b at
four weeks may be due to difficulty in detecting increases through inhibition of the AT1 receptor-mediated effects
of Ang II. Findings of differences between ACEI andin Mf gene expression in the presence of unchanged
expression in the much larger mass of renal parenchyma. AT1RA treatment on M f infiltration and VCAM-1 ex-
pression in UUO kidneys, but lack of effect of eitherLater increases in TNF-a and IL-1b mRNA likely reflect
expression by intrinsic renal cells as well as M f . treatment on ICAM-1 expression, suggest that AT1 re-
ceptor-independent mechanisms play a role in M f re-A large body of experimental and clinical evidence
supports the view that the profibrotic cytokine TGF-b1 cruitment in this model of interstitial fibrosis [30, 31].
Our results extend the findings of other investigatorsplays a major role in renal fibrosis resulting from a wide
range of causes [reviewed in 51]. On the other hand, who observed inhibition of renal TGF-b1 expression [55]
and Mf infiltration [7, 56] with ACEI or AT1RA treat-recent evidence suggests that this cytokine may also play
a counter-regulatory, anti-inflammatory role in the kid- ment. MCP-1 up-regulation is also inhibited by dietary
protein restriction [5], which inhibits the RAS by de-ney and may suppress cytokine production by glomerular
Mf [52–54]. Increased TGF-b1 expression has been ob- creasing renin mRNA [59]. Interestingly, inhibition of
MCP-1 expression by a low-protein diet was only partialserved in the remnant kidney using Northern blot analysis
[55, 56], in situ hybridization [56], immunohistology [56, 57], at two weeks after 5/6 nephrectomy. This is reminiscent
of our current observation of partial inhibition of MCP-1and enzyme-linked immunosorbent assay (ELISA) [55].
Notably, Wu et al localized TGF-b1 expression to infil- at four weeks by both ACEI and AT1RA, suggesting
that significant RAS-independent stimuli may also con-trating M f , using combined in situ hybridization and
immunohistology techniques [56]. TGF-b1 mRNA has tribute to MCP-1 expression, at least in the early phases
after 5/6 nephrectomy.also been localized to endothelial cells and mesangial
cells early in the development glomerulosclerosis [58]. The lack of suppression of IL-1b and TGF-b1 with
candesartan treatment at 8 weeks after surgery appearsOur competitive RT-PCR data confirm that TGF-b1
mRNA levels were increased approximately threefold at to be transient and of questionable significance since
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Fig. 5. Schema illustrating possible mecha-
nisms of proinflammatory cytokine induction
and Mf infiltration in the remnant kidney, and
the central role of Ang II in the pathogenesis of
progressive glomerulosclerosis and interstitial
fibrosis. Abbreviations are: Ang II, angioten-
sin II; Pgc, glomerular capillary hydraulic pres-
sure; QA, glomerular plasma flow rate; NF-kB,
nuclear factor-kB; TGF-b, transforming growth
factor-b; CAMs, cell adhesion molecules; IL-1b,
interleukin-1b; TNF-a, tumor necrosis factor-a;
ROS, reactive oxygen species.
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